US FDA investigates CT imaging quality assurance programmes
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration is investigating whether radiation overexposures that occurred during CT brain perfusion scans at an unnamed healthcare facility reflect a more widespread problem with CT quality assurance programmes1.